Navigation Links
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Date:2/20/2008

atment of patients with mantle cell lymphoma who have received at least one prior therapy. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol. VELCADE should be administered under the supervision of a physician experienced in the use of antineoplastic therapy. In the European Union and many other countries worldwide, VELCADE is approved for patients with multiple myeloma after first relapse.

Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis syndrome. Women of childbearing potential should avoid becoming pregnant while being treated with VELCADE. Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection fraction has been reported, including reports in patients with few or no risk factors for decreased left ventricular ejection fraction. There have been rare reports of acute diffuse infiltrative pulmonary disease of unknown etiology such as pneumonitis, interstitial pneumonia, lung infiltration and Acute Respiratory Distress Syndrome in patients receiving VELCADE. Some of these events have been fatal. A higher proportion of these events have been reported in Japan. There have been rare reports of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. There have been reports of gastrointestinal and intracerebral hemorrhage in associa
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
3. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
4. Cellectar Expands Clinical Management Team
5. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
8. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
11. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Top Brooklyn ... Pediatrics responds to an article, which suggests that caffeine ... Logo - http://photos.prnewswire.com/prnh/20140718/128611 A ... giving coffee to children, but now it happens rather ... A new study, published in the journal Pediatrics, discussed ...
(Date:7/21/2014)... , July 21, 2014 ... Transparency Market Research "E-Clinical Solution Software Market- Global Industry ... 2020," the global microfluidic device market was valued at ... grow at a CAGR of 13.8% from 2014 to ... million in 2020. Browse the full E-Clinical ...
(Date:7/21/2014)... Conn. , July 21, 2014 UBM ... , a leading online community for primary care ... help clinicians identify and treat victims of a variety ... of summer are packed with a host of medical ... name a few. Some of the highlights covered on ...
Breaking Medicine Technology:Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5ConsultantLive Presents Special Coverage of Summer Scourges 2ConsultantLive Presents Special Coverage of Summer Scourges 3
... 9, 2012  Unigene Laboratories, Inc. (OTCBB: UGNE) ... multiple near-term catalysts that have the potential to monetize ... months.  Management believes the key elements are in place ... balance sheet in 2012.  Unigene,s CEO, Senior Management and ...
... 2012  Robert McNally, Ph.D., President and CEO of GeoVax Labs, ... Dear Fellow Shareholders, At the start ... that we have accomplished over the past year, but it ... challenges and opportunities awaiting GeoVax in 2012 and beyond. ...
Cached Medicine Technology:Unigene Provides 2012 Business Outlook 2Unigene Provides 2012 Business Outlook 3Unigene Provides 2012 Business Outlook 4Unigene Provides 2012 Business Outlook 5Unigene Provides 2012 Business Outlook 6Unigene Provides 2012 Business Outlook 7Unigene Provides 2012 Business Outlook 8Unigene Provides 2012 Business Outlook 9Unigene Provides 2012 Business Outlook 10Unigene Provides 2012 Business Outlook 11GeoVax Labs' CEO Update Letter to Shareholders 2GeoVax Labs' CEO Update Letter to Shareholders 3GeoVax Labs' CEO Update Letter to Shareholders 4GeoVax Labs' CEO Update Letter to Shareholders 5
(Date:7/22/2014)... July 22, 2014 Getting breast implants is ... completely optional or due to medical necessity. Either way, women ... to prepare for it, says Robert Kraft, MD, Plastic Surgeon ... implant removal surgeries are performed each year in the United ... 70 percent of those procedures stem from three main problems: ...
(Date:7/22/2014)... The hair transplant experts at WeGrowHair.com / PAI ... therapy and robotic assisted hair transplantation to provide ... from hair loss. Alongside their unique Multi-Unit Hair ... (FUE) procedures via ARTAS – the world’s most ... doctors use advanced digital mapping to more accurately ...
(Date:7/21/2014)... target and kill cancer cells could boost the effectiveness ... avoid amputation, a new study reports. , Scientists at ... of a genetically engineered version of the virus used ... the virus alongside isolated limb perfusion chemotherapy given ... leg as an alternative to amputation was more ...
(Date:7/21/2014)... MillionaireCasket.com, a well-known casket manufacturer from China, has recently added ... website. In addition to this, the company is now giving ... brand new items. , MillionaireCasket.com is a reliable supplier ... for its current and prospective clients. Its hot products include ... more. According to the company’s sales manager, its website will ...
(Date:7/21/2014)... 21, 2014 Cannabis Now Magazine recently ... events this summer. During these festivals, they will strengthen ... information and resources to attendees in an effort to ... on the legitimate and beneficial side of cannabis. , ... San Francisco, the Kush Expo in Anaheim, the Champs ...
Breaking Medicine News(10 mins):Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 2Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 3Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2
... history data supports heredity,s role in shoulder tendon tearsROSEMONT, Ill., ... rotator cuff tears are at increased risk ... in the May 2009 issue of The Journal ... "This strongly suggests genetic predisposition as a possible cause for ...
... Enables Hospitals to Rapidly Notify Staff, Community and Authorities with Instant ... ... 1, 2009 -- Mobile Health Tech, the healthcare division of Gold ... Rapid Notification Alert System™. This new release allows hospitals to provide ...
... Inc. (NYSE Amex: DDD ) reported financial results ... Company will host a live conference call on May 1, ... Pharma,s President and CEO, stated, "Our top priorities continue to ... and pseudoephedrine, and the support of our existing alliances and ...
... with CDC Treatment Guidelines at the Point of ... a leading developer of drug information applications and ... e-prescribing solution EMPOWERx is now providing physicians with ... Virus as issued by the Centers for Disease ...
... HULL, England, May 1 Smith & Nephew,s Advanced Wound Management ... Patents Court, in the High Court of Justice of England and ... asserted against Smith & Nephew of the Negative Pressure Wound Therapy ... (KCI) (NYSE: KCI ). The 3 other claims ...
... N.M., May 1 Strategic Analytics Inc., the leading ... lenders, today disclosed that its LookAhead(TM) software was used ... federal regulators. Strategic Analytics software and services are used ... largest U.S. consumer loan portfolios, according to American Banker.Several ...
Cached Medicine News:Health News:Rotator Cuff Tears: Are They All in the Family? 2Health News:Rotator Cuff Tears: Are They All in the Family? 3Health News:Hospital Rapid Alert System Supports Swine Flu Pandemic Communications 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 3Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 4Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 5Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 6Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 7Health News:EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 3Health News:Strategic Analytics Reports Stress Test Achievements 2Health News:Strategic Analytics Reports Stress Test Achievements 3
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... Smith & Nephew ECTRA II systems permit ... carpal tunnel ligament endoscopically, allowing access via ... while minimizing endoscopic lens fogging with good ... complete visualization and control. ECTRA knives permit ...
Medicine Products: